07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

9819<br />

FHME<br />

57485<br />

HCASC<br />

34626<br />

Furthermore, these ancillary studies are expensive, labor intensive, and are most efficiently utilized and<br />

interpreted in the context of the morphologic features. It is the Division of Hematopathology's goal to<br />

provide the highest possible level of diagnostic consultative service, trying to balance optimal patient care<br />

with a cost-conscious approach to solving difficult diagnostic problems. All blood and bone marrow<br />

studies are available within the context of a hematopathology consultation. Requests for specific ancillary<br />

tests, including enzyme cytochemical stains, immunocytochemistry (slide immunophenotyping), and<br />

immunohistochemistry are not available through <strong>Mayo</strong> <strong>Medical</strong> <strong>Laboratories</strong> as individually ordered tests,<br />

but rather in association with a consultation. If the <strong>Mayo</strong> consultant would approach the diagnosis in a<br />

different way than the referring physician, then the <strong>Mayo</strong> consultant will call the referring physician to<br />

discuss the case prior to performing any additional studies. Referring physicians are welcome to suggest<br />

which specific ancillary studies should be performed, but before they are done, a morphologic review by<br />

one of the <strong>Mayo</strong> consulting staff hematopathologists will confirm the diagnostic problem presented by the<br />

morphologic differential diagnosis. The following algorithms are available in Special Instructions:<br />

-Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation -Myeloproliferative<br />

Neoplasm: A Diagnostic Approach to Peripheral Blood Evaluation -Laboratory Approach to the<br />

Diagnosis of Amyloidosis<br />

Useful For: Obtaining a rapid, expert second opinion on specimens referred by the primary pathologist<br />

Obtaining special studies not available locally Note: If the need for special studies is anticipated,<br />

appropriate material should be sent. See Specimen Required.<br />

Interpretation: Results will be reported as a morphologic description followed by a specific diagnosis<br />

and also includes a description of the ancillary test results and an interpretive comment. When the case is<br />

completed, all results will be communicated by a phone call and a formal pathology report. Through this<br />

enhanced consultative process, we strive to bring the customer the highest quality of diagnostic<br />

hematopathology, aiming to utilize only those ancillary tests that support the diagnosis in a cost-effective<br />

manner, and to provide a rapid turnaround time for diagnostic results.<br />

Reference Values:<br />

This request will be processed as a consultation. An interpretation will be provided for every case.<br />

Appropriate studies and/or stains (as described in Specimen Required) will be performed, only if<br />

indicated, and charged separately.<br />

Clinical References: Not applicable<br />

Hematoxylin-Eosin-Mayer's Progressive Stain<br />

Reference Values:<br />

The laboratory will provide a pathology consultation and stained slide.<br />

Hemiplegic Migraine Evaluation<br />

Reference Values:<br />

An interpretive report will be faxed and/or mailed under separate cover.<br />

<strong>Test</strong> Performed by: Athena Diagnostics<br />

377 Plantation Street<br />

Four Biotech Park<br />

Worcester, MA 01605<br />

Hemochromatosis Cascade<br />

Clinical Information: Hereditary hemochromatosis (HH) is an autosomal recessive disorder<br />

characterized by increased intestinal absorption of iron with deposition in the liver, pancreas, and multiple<br />

other organs. The gene for hemochromatosis was discovered in 1996 and named HFE. Two point<br />

mutations were initially described, C282Y and H63D. Approximately 0.5% of Caucasians in the United<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 869

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!